Genetically engineered mesenchymal stem cells: applications in spine therapy.
Spine disorders and intervertebral disc degeneration are considered the main causes for the clinical condition commonly known as back pain. Spinal fusion by implanting autologous bone to produce bony bridging between the two vertebrae flanking the degenerated-intervertebral disc is currently the most efficient treatment for relieving the symptoms of back pain. However, donor-site morbidity, complications and the long healing time limit the success of this approach. Novel developments undertaken by regenerative medicine might bring more efficient and available treatments. Here we discuss the pros and cons of utilizing genetically engineered mesenchymal stem cells for inducing spinal fusion. The combination of the stem cells, gene and carrier are crucial elements for achieving optimal spinal fusion in both small and large animal models, which hopefully will lead to the development of clinical applications.
Aslan
Hadi
H
Skeletal Biotech Lab, Hebrew University, The Hebrew University of Jerusalem- Hadassah Medical Center, Jerusalem, Israel.
Sheyn
Dima
D
Gazit
Dan
D
D000818:Animals; D005818:Genetic Engineering; D006801:Humans; D045164:Mesenchymal Stem Cell Transplantation / Q000379:methods*; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism; D008954:Models, Biological; D010012:Osteogenesis / Q000235:genetics; D044968:Regenerative Medicine; D013122:Spinal Diseases / Q000628:therapy*; D013123:Spinal Fusion / Q000379:methods; D013131:Spine / Q000166:cytology / Q000378:metabolism